LOS ANGELES, Sept. 21, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Vitamin Shoppe, Inc. (“Vitamin Shoppe” or the “Company”) (NYSE:VSI) for possible violations of federal securities laws from March 1, 2017 through August 6, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the October 27, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, Vitamin Shoppe made false and/or misleading statements, and/or failed to disclose: that the Company’s retail segment was continuing to dramatically decline; that the Company’s ongoing “reinvention plan” had been unsuccessful and brought more than $168 million in goodwill impairment, and it was not properly recognizing that impairment charge; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this news was announced, shares of Vitamin Shoppe declined in value materially, which caused investors harm according to the Complaint.
Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.
Contact:
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]
http://lundinlawpc.com/


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Italy Fines Apple €98.6 Million Over App Store Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 



